BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1312121)

  • 1. The nucleotide sequences of wild-type coxsackievirus A9 strains imply that an RGD motif in VP1 is functionally significant.
    Chang KH; Day C; Walker J; Hyypiä T; Stanway G
    J Gen Virol; 1992 Mar; 73 ( Pt 3)():621-6. PubMed ID: 1312121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nucleotide sequence of coxsackievirus A9; implications for receptor binding and enterovirus classification.
    Chang KH; Auvinen P; Hyypiä T; Stanway G
    J Gen Virol; 1989 Dec; 70 ( Pt 12)():3269-80. PubMed ID: 2558158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RGD-dependent entry of coxsackievirus A9 into host cells and its bypass after cleavage of VP1 protein by intestinal proteases.
    Roivainen M; Hyypiä T; Piirainen L; Kalkkinen N; Stanway G; Hovi T
    J Virol; 1991 Sep; 65(9):4735-40. PubMed ID: 1870199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology and evolution of coxsackievirus A9.
    Santti J; Harvala H; Kinnunen L; Hyypiä T
    J Gen Virol; 2000 May; 81(Pt 5):1361-72. PubMed ID: 10769080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular biological characterization of enterovirus variant isolated from patients with aseptic meningitis.
    Jung YT; Kim GR; Paik SY
    Exp Mol Med; 1998 Jun; 30(2):101-7. PubMed ID: 9873830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology of coxsackievirus B4 and disclosure of the correct VP1/2A(pro) cleavage site: evidence for high genomic diversity and long-term endemicity of distinct genotypes.
    Mulders MN; Salminen M; Kalkkinen N; Hovi T
    J Gen Virol; 2000 Mar; 81(Pt 3):803-12. PubMed ID: 10675418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of coxsackievirus A16 reveals a new genetic group of enteroviruses.
    Pöyry T; Hyypiä T; Horsnell C; Kinnunen L; Hovi T; Stanway G
    Virology; 1994 Aug; 202(2):982-7. PubMed ID: 8030260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of neutralizing antibodies by synthetic peptides representing the C terminus of coxsackievirus A9 capsid protein VP1.
    Pulli T; Roivainen M; Hovi T; Hyypiä T
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2249-53. PubMed ID: 9747735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The crystal structure of coxsackievirus A9: new insights into the uncoating mechanisms of enteroviruses.
    Hendry E; Hatanaka H; Fry E; Smyth M; Tate J; Stanway G; Santti J; Maaronen M; Hyypiä T; Stuart D
    Structure; 1999 Dec; 7(12):1527-38. PubMed ID: 10647183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foot-and-mouth disease virus can utilize the C-terminal extension of coxsackievirus A9 VP1 for cell infection.
    Leippert M; Pfaff E
    J Gen Virol; 2001 Jul; 82(Pt 7):1703-1711. PubMed ID: 11413382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient RGD-independent entry process of coxsackievirus A9.
    Roivainen M; Piirainen L; Hovi T
    Arch Virol; 1996; 141(10):1909-19. PubMed ID: 8920824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombination Events and Conserved Nature of Receptor Binding Motifs in Coxsackievirus A9 Isolates.
    Hietanen E; Susi P
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31935831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-saturation mutagenesis of the PALTAVETG motif in coxsackievirus A9 capsid protein VP1 reveals evidence of conservation of a periodic hydrophobicity profile.
    Airaksinen A; Roivainen M; Stanway G; Hovi T
    J Gen Virol; 1999 Aug; 80 ( Pt 8)():1919-1927. PubMed ID: 10466787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The coxsackievirus A9 RGD motif is not essential for virus viability.
    Hughes PJ; Horsnell C; Hyypiä T; Stanway G
    J Virol; 1995 Dec; 69(12):8035-40. PubMed ID: 7494317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of enteroviruses isolated from patients with aseptic meningitis in Korea, 2005.
    Lee ST; Ki CS; Lee NY
    Arch Virol; 2007; 152(5):963-70. PubMed ID: 17238012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tropism of Coxsackie virus A9 depends on the +1 position of the RGD (arginine- glycine- aspartic acid) motif found at the C' terminus of its VP1 capsid protein.
    Ioannou M; Stanway G
    Virus Res; 2021 Mar; 294():198292. PubMed ID: 33388395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification.
    Oberste MS; Maher K; Kilpatrick DR; Pallansch MA
    J Virol; 1999 Mar; 73(3):1941-8. PubMed ID: 9971773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genotypic characterization of enteroviral antigenic variants isolated in eastern Canada.
    Drebot MA; Campbell JJ; Lee SH
    Virus Res; 1999 Feb; 59(2):131-40. PubMed ID: 10082385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of human enteroviruses in clinical samples: comparison between VP2, VP1, and RNA polymerase regions using RT nested PCR assays and direct sequencing of products.
    Casas I; Palacios GF; Trallero G; Cisterna D; Freire MC; Tenorio A
    J Med Virol; 2001 Sep; 65(1):138-48. PubMed ID: 11505456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete nucleotide sequence of a coxsackie B5 virus and its relationship to swine vesicular disease virus.
    Zhang G; Wilsden G; Knowles NJ; McCauley JW
    J Gen Virol; 1993 May; 74 ( Pt 5)():845-53. PubMed ID: 8388019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.